Aparna Ahuja's most recent trade in T2 Biosystems Inc was a trade of 600,000 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 20, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems Inc | Aparna Ahuja | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2022 | 600,000 | 600,000 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Aparna Ahuja | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.48 per share. | 06 Jan 2022 | 61,988 | 107,611 (0%) | 0% | 0.5 | 29,754 | Common Stock |
T2 Biosystems Inc | Aparna Ahuja | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 153,664 | 169,599 (0%) | 0% | - | Common Stock | |
T2 Biosystems Inc | Aparna Ahuja | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 153,664 | 307,328 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Aparna Ahuja | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 460,992 | 460,992 | - | - | Restricted Stock Units |